Skip to main content
Clinical Trials/NCT05447143
NCT05447143
Completed
Not Applicable

Examination of the Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis: A Randomized Controlled Single-Blind Trial

Muğla Sıtkı Koçman University1 site in 1 country60 target enrollmentSeptember 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Muğla Sıtkı Koçman University
Enrollment
60
Locations
1
Primary Endpoint
Fatigue Severity Scale
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Multiple Sclerosis (MS) is a chronic, inflammatory, neurodegenerative, and autoimmune disease that progresses with progressive neurological dysfunction and affects the central nervous system. A multidisciplinary rehabilitation approach is crucial in the systematic and supportive treatment of MS. Exercise training is a therapeutic approach that minimizes functional capacity loss and slows progression in MS. Randomized controlled studies have shown that exercise training improves physical fitness, reduces motor fatigue, and improves the quality of life and psychological state in individuals with MS.

When the literature is examined, it is seen that popular exercises such as pilates, yoga, and Tai-Chi are used in addition to aerobics, strengthening, endurance, and stretching exercises in the treatment of individuals with MS. In order to eliminate the economic burden, which is one of the exercise barriers of individuals, and to gain exercise habits, home exercise programs should be expanded. When the literature is examined, it is emphasized that the importance of home exercise programs is emphasized, and it is very important in the treatment of patients who cannot attend an exercise program, especially by going to any center for various reasons. However, there is little information on the effectiveness and content of home exercise programs in patients with MS. From this point of view, this study is capable of supporting the missing part of the literature.

Registry
clinicaltrials.gov
Start Date
September 30, 2021
End Date
June 15, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Muğla Sıtkı Koçman University
Responsible Party
Principal Investigator
Principal Investigator

Banu BAYAR

Principal investigator, Head of Physiotherapy and Rehabilitation Department, Pt. PhD. Prof.

Muğla Sıtkı Koçman University

Eligibility Criteria

Inclusion Criteria

  • To be between the ages of 18-65
  • Being diagnosed with MS according to McDonald criteria
  • Having an EDSS score between 0-5.5
  • Being in the Relapsing Remitting class as a clinical subtype of MS
  • Not having any nervous system pathology other than MS
  • Not having an MS attack in the last 1 month
  • To ensure full cooperation and adaptation throughout the study.

Exclusion Criteria

  • Being in an exacerbation period
  • To have participated in a regular physical activity program in the last 6 months
  • Having an orthopedic, cardiopulmonary or psychiatric disease that prevents exercise
  • Continuing another exercise therapy
  • Not volunteering to participate in the study
  • Having problems with reading comprehension

Outcomes

Primary Outcomes

Fatigue Severity Scale

Time Frame: Baseline- after 8 weeks (after treatment)

The Fatigue Severity Scale questionnaire contains nine statements that rate the severity of fatigue symptoms. A total score of less than 36 suggests that patient may not be suffering from fatigue. A higher score is indicated high level of fatigue.

Timed up and go with 25 steps walking test

Time Frame: Baseline- after 8 weeks (after treatment)

Timed up and go: Patients wear their regular footwear and can use a walking aid, if needed. 1. The patient starts in a seated position 2. The patient stands up upon therapist's command: walks 3 meters, turns around, walks back to the chair and sits down. 3. The time stops when the patient is seated. 4. Be sure to document the assistive device used. Note: A practice trial should be completed before the timed trial. High falling risk\>13.5 seconds. The 25 steps walking test is a quantitative mobility and leg function performance test based on a timed 25-walk. The patient is directed to one end of a clearly marked 25-foot course and is instructed to walk 25 feet as quickly as possible, but safely. The time is recorded.

Brief International Cognitive Assessment for MS (BICAMS)

Time Frame: Baseline- after 8 weeks (after treatment)

The Brief International Cognitive Assessment for MS (BICAMS) initiative was undertaken to recommend a brief, cognitive assessment for MS that is optimized for small centers. BICAMS was particularly focused on international use, to facilitate comparison across settings. An expert committee of twelve neurologists and neuropsychologists representing the main cultural groups that have so far contributed extensive data about cognitive dysfunction in MS was convened. The opinions generated from the meeting are published elsewhere. Consensus was also achieved on optimal measures for learning and memory in MS patients, time permitting: the initial learning trials of the second edition of the California Verbal Learning Test (CVLT2) and the revised Brief Visuospatial Memory Test (BVMTR).

Berg Balance Scale

Time Frame: Baseline- after 8 weeks (after treatment)

The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. A score of 56 indicates functional balance. A score of \< 45 indicates individuals may be at greater risk of falling.

Secondary Outcomes

  • Mulitple Sclerosis Quality of life- 54(Baseline- after 8 weeks (after treatment))
  • Beck Depression and Anxiety Scale(Baseline- after 8 weeks (after treatment))

Study Sites (1)

Loading locations...

Similar Trials